During the past decade, Azienda Ospedaliera dei Colli conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 2 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera dei Colli" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Fondazione Ricerca Traslazionale" with 2 trials sponsored, "National Cancer Institute, Naples" with 2 trials sponsored and "Amryt Pharma" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera dei Colli" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arcispedale Santa Maria Nuova-IRCCS" with 1 trials as a collaborator, "Azienda Ospedaliero-Universitaria di Parma" with 1 trials as a collaborator and "Centro di Riferimento Oncologico - Aviano" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera dei Colli" are "Pulmonary Disease, Chronic Obstructive" (2 trials), "Advanced Cancer" (1 trials), "Antiplatelet Therapy" (1 trials), "Cancer" (1 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera dei Colli" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera dei Colli" are "Drug" (17 trials), "Device" (2 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sotorasib" (2 trials), "AMG 510" (1 trials), "Amivantamab" (1 trials), "Aspirin 100 mg OD plus clopidogrel 75 mg OD" (1 trials) and "Aspirin 100mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera dei Colli" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera dei Colli". 1 are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Azienda Ospedaliera dei Colli, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera dei Colli, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Azienda Ospedaliera dei Colli has several departments that took part in Clinical trials: "AORN Ospedali dei Colli Ospedale Monaldi; UOC Pneumologia ad indirizzo Oncologico" - 10 trials, "Aorn Osp. Dei Colli- Po Vincenzo Monaldi, U.O.C. Cardiologia" - 3 trials, "Aorn Osp. Dei Colli- Po Vincenzo Monaldi, U.O.C. Cardiologia - S.U.N." - 3 trials